K
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
Price:
59.82
INR
1.41%
Market Cap:
₹1.3B
Relative Value
The Relative Value of one KREBSBIO stock under the Base Case scenario is hidden INR. Compared to the current market price of 59.82 INR, Krebs Biochemicals and Industries Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KREBSBIO Relative Value
HIDDEN
Multiples Across Competitors
KREBSBIO Competitors Multiples
Krebs Biochemicals and Industries Ltd Competitors
Krebs Biochemicals and Industries Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
K
|
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
|
1.3B INR | 5.6 | -5.6 | -35.4 | -21.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
966.3B USD | 14.8 | 46.8 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.1B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
